Latest News

The Buffalo News reported that UB’s Center for Advanced Technology in Big Data and Health Sciences has awarded grants to nine health sciences projects by eight companies, including projects led by Jonathan Lovell and Jun Xia.

The Associated Press reported that POP Biotechnologies, founded by Jonathan Lovell, completed a study on a new recombinant COVID vaccine, EuCorVac-19.

Projects focus on cancer therapies, robotic clot removal catheters, and mRNA vaccines, among other technologies

UB continues to rank among the top public universities in the nation, according to the latest rankings released today by U.S. News & World Report.

Medical student Anna Walsh started a STEM camp for kindergartners through seventh-graders at a school in South Africa.

The American Lung Association featured Ruogang Zhao  in an article about pulmonary fibrosis researchers, noting that Zhao and his team developed an experimental model to show how macrophages contribute to the progression of lung fibrosis.

Promising approach targets multiple pathogenic hallmarks of the disease.

Medical Xpress quoted Jonathan Lovell  in an article about developing a novel immunotherapy approach to Alzheimer’s disease treatment that targets multiple epitopes.